Articles Vol. 67 No. 9 25/09/2026

PRELIMINARY EVALUATION OF CLINICAL IMPROVEMENT IN CHILDRENT WITH NOCTURNAL ENURESIS TREATED WITH CDN GRANULES

Tran Thi Phuong Linh, Dang Thai Tung
0 Views
0 Downloads
Abstract

Objectives: Initial evaluation of the clinical improvement and safety of CDN granules in pediatric patients with non-organic enuresis

Patients and Methods: An observational study was conducted on 40 pediatric patients (aged 5-15 years) diagnosed with non-organic enuresis according to DSM-5 criteria, presenting with the Kidney Qi Deficiency pattern. Patients took CDN granules for 4 weeks and were followed up for 12 weeks to monitor enuresis frequency, Traditional Chinese Medicine symptoms, response rates, relapse rates, and safety indicators.

Results: The mean age was 7.98 ± 2.34 years, with a male-to-female ratio of 1.35:1. After 4 weeks of treatment, the mean enuresis frequency decreased from 5.35 ± 1.89 to 2.87 ± 1.54 /week (p<0,05). The rate of good and fair response reached 75%. At 4 and 8 weeks post-treatment, the good and fair response rates showed a downward trend. TCM symptoms (deep sleep with difficulty waking up, fatigue, aversion to cold, and cold extremities) all showed a tendency to improve. (p<0,05). No clinical adverse effects were recorded; changes in hematological parameters as well as liver and kidney functions were not statistically significant (p>0,05).

Conclusions: Initial research results of CDN granules show a positive signal in reducing enuresis frequency in a small-scale before-and-after study. Randomized controlled trials with longer treatment durations are needed to confirm its efficacy and safety.

References
[1]
1. Caldwell PH, Deshpande AV, Von Gontard A. Management of nocturnal enuresis BMJ. 2013 Oct 29; 347:f 6259. DOI: 10.1136/bmj.f6259. Google Scholar
[2]
2. Khoa Y học cổ truyền, Trường Đại học Y Hà Nội. Nhi khoa Y học cổ truyền. Hà Nội: Nhà xuất bản Y học; 2017, trang 227-34 Google Scholar
[3]
3. Nguyễn Nhược Kim (chủ biên). Phương tễ học. Nhà xuất bản Y học ; 2009, trang 111 Google Scholar
[4]
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed., text revision (DSM-5-TR). Washington DC; 2022. p. 389–392 Google Scholar
[5]
5. 郑筱萸,(2002). 中药新药临床研究指导原则 (试行), 中国医药科技出版社. Google Scholar
[6]
6. Liu Qin,Cheng Min, et al. Meta-analysis of the Prevalence and Factors Affecting Enuresis in Chinese Children and Adolescents[J]. Chinese General Practice, 2025, 28(06): 763-770. DOI: 10.12114/j.issn.1007-9572.2024.0205. Google Scholar
[7]
7. 黎辉军. 桑螵蛸散合缩泉丸治疗小儿遗尿的临床观察. 黑龙江中医药大学学报. 2009;11(1):28–34. Google Scholar
[8]
8. Huanling Lai, et al. Effect of Suo Quan Wan on TRPV1 expression in the bladder of rats with bladder outlet obstruction. BMC Complement Altern Med. 2015;15:424. DOI:10.1186/s12906-015-0898-7 Google Scholar
[9]
9. Zhang Y, Zhang J, et al. Suo Quan Wan ameliorates bladder overactivity and regulates neurotransmission via Myosin Va protein expression. Phytomedicine. 2021;104. DOI: 10.1016/j.phymed.2022.154265 Google Scholar
[10]
10. Shen Xiaoyu, Gua Zhuying, et al. Clinical observation of Suoquan capsule and Xingpi Yanger granule treatment on infantile enuresis based on the clinical syndromes[J]. Chinese Journal of General Practice, 2019, 17(2): 173-175,204. DOI: 10.16766/j.cnki.issn.1674-4152.000631 Google Scholar